Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:00 Fri 8:30-15:00
07:28
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

 

WFH 2016 World Congress

 

24-28 July 2016 Orlando
FAQs
   
Discussion forum - WFH 2016 World Congress
    Topic - Hemophilia – clinical

If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER.
 

Poster: 91
Visits: 15
Title: Effect of factor VIII concentration on the risk of spontaneous bleeding following treatment with rFVIII (turoctocog alfa) in patients with severe hemophilia A
Authors: Andreas Groth ,
Centre: Novo Nordisk A/S, Sborg, Denmark

You must be registered to reply or comment.

EFFECT OF FACTOR VIII CONCENTRATION ON THE RISK OF SPONTANEOUS BLEEDING FOLLOWING TREATMENT WITH RFVIII (TUROCTOCOG ALFA) IN PATIENTS WITH SEVERE HEMOPHILIA A

Harley Souter
Thread initiator
Subspeciality
Reg: 7/15/2016 1:13:00 PM
Comment# 1
I invite healthcare professionals to open debate around the issues raised in my poster, both those relating to research and to clinical practice.

Comment added on 7/19/2016 12:48:00 PM 
     
You must be registered to reply or comment.



Most viewed poster for this congress
Poster: 13
Visits: 590
Title: Algorithmic evidence-based phenotype screening and collaborative approach to attacking symptoms of nonadherence in patients with bleeding disorders
Authors: Jay Bryant-Wimp , Jay Bryant-Wimp, RPh
Centre: Integrite Solutions

Poster most viewed in this topic
Poster: 97
Visits: 120
Title: Safety and efficacy of turoctocog alfa for prophylaxis and treatment of bleeding episodes in patients with severe hemophilia A: results from the guardian2 trial
Authors: Elena Santagostino ,
Centre: Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Maggiore Hospital Policlinico, Milan, Italy


 






PosterSessionOnline
Logo Draft
 
Logo Cert